Wound Therapy Devices Market – By Product Type, By Wound Type, By End Use – Global Forecast, 2025 – 2034

Wound Therapy Devices Market Size

The global wound therapy devices market was valued at USD 3.5 billion in 2024 and is projected to exhibit 4.5% CAGR from 2025-2034. The escalating incidence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is a key contributor to the growth of the market.
 

According to the World Health Organization (WHO), there are roughly 422 million diabetics worldwide, and 15%-25% of these individuals will develop diabetic foot ulcers at some point during their lives. These wounds are slow to heal and therefore require specialized care, creating an opportunity for advanced wound therapy devices. The increasing incidences of diabetes, obesity, and vascular disease has further escalated the need for negative pressure wound therapy (NPWT) and pressure relief systems to therapeutically facilitate healing and avoid complications. The rise in prevalence of chronic wounds necessitates the presence of effective wound therapy devices in the healthcare arena.
 

Additionally, the growing global population of older adults also have an increased frequency of conditions that negatively affect wound healing, such as inflexible skin, reduced skin elasticity, reduced circulation, and diabetes. According to the United Nations, by 2050, 1 in 6 people will be over the age of 65, representing an increase from 1 in 11 people 2019. Older patients who are also quite immobile or have very limited mobility, are at increased risk of advanced pressure ulcers. According to the Agency for Healthcare Quality and Research, pressure ulcers impact about 2.5 million patients in the U.S. each year. These changing demographics will benefit the market for wound therapy devices as aging adults need ongoing, continuous healing care.
 

The wound therapy devices market is a subsection of the medical device industry that develops, manufactures, and distributes devices and technologies that help, assist, and expedite the healing of acute and chronic wounds. Wound therapy devices are used in the management of a variety of wounds including surgical wound care, pressure ulcers, diabetic foot ulcers, burns, and traumatic injuries.
 

Wound Therapy Devices Market Trends

• The demand for small, lightweight, user-friendly wound therapy devices that can be used in the home setting continues to grow. This is due to rising healthcare costs, patients wanting to access care in their own home, and improved portable technology, including wearable NPWT systems.
   
• These portable technologies allow patient mobility and convenience while remaining clinically effective, and are particularly useful for patients with chronic wounds needing long-term treatment, shortening the length of hospital stays and use of hospital resources, and allowing for greater efficiency in the overall healthcare system.
   
• The integration of digital health, with smart sensors, telemonitoring and technology for remote access, is redefining how wounds are managed. Today’s devices are integrated with technology that documents a patient’s healing progress, measures moisture levels, and detects indicators of infection allowing for personalized care, evidence-based changes of care, and improved patient outcomes.
   
• With technology that enables real-time data collection, in conjunction with telemedicine, wound providers are able to enhance patient care and contact with their healthcare team. Remote consultations and clinical decisions made now increase patient access to care and reduce the need for clinic or hospital visits.
   
• Healthcare systems worldwide are moving away from volume-based care models of reimbursement to value-based approaches that improve patient outcomes and cost-effectiveness.
   
• Therefore, decisions related to wound management are being made differently as buyers consider devices that achieve the best healing results and minimized complications, hospital readmissions, and overall costs of treatment. For example, manufacturers are conducting clinical studies and collecting real world evidence that promote clinical and economic advantages resulting in greater adoption amongst institutions.
   

Wound Therapy Devices Market Analysis

Based on product type, the market is segmented into negative pressure wound therapy, hyperbaric oxygen therapy, electric stimulation devices, pressure relief devices, and other product types. The negative pressure wound therapy segment dominated the market with the largest revenue share of 36.2% in 2024.
 

• The rising prevalence of chronic conditions such as diabetes, obesity, and vascular diseases has led to an increase in non-healing wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers. According to the World Health Organization (WHO), the global diabetes figure grew from 200 million in 1990 to 830 million in 2022, with an estimated 15% of patients with diabetes developing a foot ulcer at some point in their lifetime. These hard-to-heal wounds often do not respond to standard treatments, leading to the integral role of Negative Pressure Wound Therapy (NPWT) devices in advanced wound care.
   
• NPWT works to improve the healing trajectory of wounds by eliminating excess fluid, reducing edema, and increasing blood flow to the tissue, making it especially suited to managing challenging, chronic wounds across both hospital and community care. The prevalence of chronic conditions is only going to continue to rise, which will in turn drive the use of advanced wound care modalities such as NPWT.
   
• After surgery, the leading cause for postprocedural care concerns remain Surgical site infections and wound dehiscencement, and NPWT devices have demonstrated better outcomes for surgical wounds by providing a sealed environment with increased granulation while minimizing potential infection. .
   
• NPWT has established the practice of NPWT for not only closed surgical wounds, but of also managing open surgical wounds amongst patients at highest risk, and rates of surgical procedures performed worldwide continue to be on the rise.
   
• Therefore, the aforementioned factors are expected to significantly boost segment growth over the forecast period.
   

Based on wound type, the wound therapy devices market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment dominated the market with the largest revenue of USD 2.4 billion in 2024.
 

• The increasing number of diabetes cases globally has led to an increased incidence of diabetic foot ulcers, which are one of the most common and difficult chronic wounds. According to the International Diabetes Federation (IDF), approximately 15% of patients with diabetes will get foot ulcers during their lifetime.
   
• These ulcers also generally do not respond to conventional treatment and typically require advanced wound care therapy devices. The increasing prevalence of diabetes and its complications represent an ongoing opportunity for growth in advanced wound therapy devices.
   
• Given that life expectancy is increasing, the growing geriatric population will experience a higher risk of chronic wounds. The United Nations Department of Economic and Social Affairs project that the number of individuals over 65 years old will increase from 703 million in 2019 to about 1.5 billion by 2050. Various physical changes associated with aging, including but not limited to, decreased skin elasticity, impaired circulation, and chronic conditions like diabetes or limited mobility status indicate that the elderly population is vulnerable to the development of wounds.
   
• Pressure ulcers and venous leg ulcers are more common and may be more significant in geriatric care settings. This growing demographic will further increase the need for advanced wound therapy devices to help reduce healing times, avoid complications, and cut down on burdens into healthcare facilities and care providers.
   
• Hence, the aforementioned factors are expected to boost segment growth over the forecast period.
   

Based on end use, the wound therapy devices market is segmented into hospitals, specialty clinics, and other end users. The hospitals segment dominated the market with a share of 54.2% in 2024.
 

• Hospitals perform many surgical acts every day, including orthopedic, cardiovascular, and general surgeries. Each of these procedures creates a wound that requires complex management to prevent complications of infection, dehiscence, and other adverse events due to delayed wound healing.
   
• Wound therapy devices, particularly negative pressure devices and specialized dressings and other advanced wound therapy techniques, are necessary to ensure ideal outcomes and the prevention of hospital-acquired conditions. The surge in surgical procedures around the world has required hospitals to rely on a variety of wound therapy devices to improve recovery time and patient outcomes.
   
• The hospital environment also provides all-encompassing support to properly manage wounds, both acute and chronic, from trained clinicians, consultants, and wound care specialists to multidisciplinary wound care teams who can employ complicated methods and procedures for wound management.
   
• Hospitals are also able to use costly specialty devices such as hyperbaric oxygen chambers, electronic stimulation systems, and other sophisticated and advanced equipment to treat wounds in ways that are simply impossible in the community.
   
• Therefore, the aforementioned factors are expected to significantly boost segment growth over the forecast period.
   

The North America wound therapy devices market was valued at USD 1.5 billion in 2024 and is expected to grow at a CAGR of 4.4% over the forecast period. The market is driven by the increasing incidence of chronic wounds across the region.
 

The U.S. market is projected to grow significantly from USD 1.4 billion in 2024 to USD 2.1 billion by 2034.
 

• The U.S. has high rates of chronic illness, such as diabetes, cardiovascular disease, and obesity, all of which are principal contributors to non-healing wounds, such as diabetic foot ulcers and venous leg ulcers. For instance, more than 37 million U.S. individuals have diabetes, according to the Centers for Disease Control and Prevention (CDC).
   
• This burden of chronic disease creates a high demand for advanced wound therapy devices in the acute care, particularly in hospitals, wound care centers, and outpatient settings that are designed for treating chronic and non-healing wounds.
   
• The infrastructure of the U.S. health care system includes a network for health care practitioners, specialists, and comprehensive use of medical devices and medical technology. Advanced wound therapy devices, such as negative pressure wound therapy (NPWT), oxygen therapy devices, and wound monitoring sensors can be utilized in hospitals, surgical centers, and long-term care environments.
   
• This technology-rich environment helps to further incorporate and implement new devices that can enhance wound healing outcomes in addition to reducing hospital response rates and allowing facilities support for institution-level quality improvement initiatives.
   
• Therefore, the aforementioned factors are expected to significantly boost regional growth over the forecast period.
   

Europe wound therapy devices market was valued at USD 873.8 million in 2024 and is expected to grow at a CAGR of 4.2% over the forecast period.
 

• In Europe, the population is transforming with an increasing numbers of citizens age over 65. Eurostat reveals that the population group age 65 and over in the EU-27 increased from 20.8% in 2021 to 21.1% in 2022 with the projected total materials to be working towards 31.3% by 2100. The elderly population is more likely to suffer from chronic wounds associated with skin will thin, decreasing mobility, and further comorbidities such as diabetes and vascular disease.
   
• Moreover, the World Health Organization (WHO) indicates that about 25% of adults age 65 and over in Europe have diabetes, significantly increases chances of developing chronic wounds. Therefore, this population will increase the need for advanced wound therapy devices in hospitals and community care across Europe, and is most notable in the regions of Germany, Italy, and France, where the elderly population is more highly concentrated. The demographic transformation of this population indicates a prolonged growth in wound care demand across the European health care state, systems, and care processes.
   
• European countries endorse universal healthcare schemes, which allow for advanced medical technologies to be utilized since all patients are afforded care without payment at the point of contact. Furthermore, with public expenditure or funds being applied ongoing, healthcare treatments, interventions, and assessments with complex reimbursement setting ensure that progress towards realize wound therapy devices can be adapted to current practices as required in any inpatient (hospital) and outpatient (community) health care setting.
   
• The health authority systems in the UK, Sweden, and the Netherlands include reimbursement frameworks for negative pressure wound therapy (NPWT) and other negative pressure type devices, encouraging clinicians to easily utilize the normative behaviours deployed. The overall support from clinical and health structure assists clinicians in implementing evidence-based wound care
   

The wound therapy devices market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The NHS is shifting the focus of care delivery from the hospital to the community to save money and to improve patient outcomes. This will accelerate the uptake of portable and easy to use wound therapy devices which the patient can use within their home, or while being treated in an outpatient clinic.
   
• The rise in the number of district nursing services and the establishment of community-based clinics for wound care in the UK, will facilitate this shift, thereby creating a need for small devices such as negative pressure wound therapy (NPWT) in a non-acute setting.
   
• Due to NHS trusts and Clinical Commissioning Groups (CCGs) budget constraints, they are always looking for value for money. Devices which have strong clinical evidence to support healing more quickly, less chance of infection and reduced long-term care costs always get approved with favourable reimbursement rates.
   
• That follows through with the recent development of excellent wound therapy devices which have been made affordable for use by clinical staff through advanced technologies and demonstrate cost-effectiveness for implementation by the National Health Service (NHS) and are based on guidelines from NHS Supply Chain and National Institute of Clinical Excellence (NICE).
   
• Hence, the above-mentioned factors are propelling the market growth in the region.
   

The Asia Pacific wound therapy devices market is expected to grow at the fastest CAGR of 5.1% over the forecast period.
 

• The Asia-Pacific region has seen rapid growth in diabetes incidence with largest populations of diabetes in the world found in China, India and Indonesia. As diabetic foot ulcers and chronic wounds related to failure of glycemic control rise, more healthcare providers are utilizing advanced wound technologies and therapy.  Equipment such as advanced negative pressure wound therapy (NPWT), hydrocolloid dressings and oxygen therapy systems are gaining traction among hospitals and providers of wound care as healthcare providers become increasingly aware of these issues.
   
• The healthcare infrastructure in APAC is receiving sizable investments from the public and private sectors to realize a progressive framework and safe environment for effective delivery of healthcare. Countries such as China, Vietnam, and the Philippines are making strides in both expanding the number of hospitals and increasing the capacity to hospitals through new construction or modifications that better facilitate the practice of surgical care, infection control practices, and advanced management of wounds.
   
• The improvements in healthcare infrastructure, the increased investment in healthcare technology, and the subsequent adoption of advanced wound therapy devices in China, Vietnam and the Philippines are expected to advance and improve throughout APAC, particularly among tertiary hospitals and urban based medical centres, as medical facilities pursue international standards and the avoidance of adverse events associated with post-operative complications.
   

Japan wound therapy devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan's aging population is among the oldest in the world, with 29.1% of its population being more than 65 years of age, in 2021, according to the World Health Organization. This population of individuals often have chronic wounds, including pressure ulcers, diabetic foot ulcers, and venous leg ulcers, because of skin stiffness/not being able to move.
   
• Japan has a well-developed healthcare system and access to medical technologies, therefore there are likely several healthcare facilities available that are sophisticated enough to quickly deliver or enable more advanced wound therapy devices like negative pressure wound therapy, electrical stimulation and oxygen therapy systems.
   
• Japan's healthcare system operates with a patient-centered approach about quality care; thus, innovative approaches to wound management, including new innovative devices, are delivered and implemented, and the system supports the knowledge and skill set of qualified medical professionals to implement care protocols.
   
• Therefore, the aforementioned factors are expected to significantly boost regional growth over the forecast period.
   

Brazil wound therapy devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• In Brazil, an upsurge in chronic health conditions, including diabetes and obesity, has led to an increase in chronic wounds, including diabetic foot ulcers and pressure ulcers. The Brazilian Ministry of Health estimates that Brazil performs approximately 55,000 amputations annually related to diabetes, which represent roughly 70% of all amputations performed.
   
• Increasing rates of chronic health conditions creates more demand for advanced wound therapy devices that enhance healing outcomes, minimize infection, and appropriately manage complex wounds during the hospital stay and outpatient services.
   
• Brazil continues to develop its healthcare infrastructure in hospitals offering surgery, wound care clinics, and specially designed care facilities.
   
• The expansion of healthcare infrastructure will facilitate further use of advanced wound therapy devices such as negative pressure wound therapy devices (NPWT), antimicrobial dressings, and portable systems, which are required for complex wound management and improving patient health outcomes.
   
• Therefore, the aforementioned factors are expected to significantly boost regional growth over the forecast period.
   

Middle East and Africa: The Saudi Arabia wound therapy devices market is expected to experience significant and promising growth from 2025 to 2034.

• The Middle East and Africa (MEA) region is on the rise in diabetes cases. 3 countries, Saudi Arabia, UAE, and South Africa have specific, but the International Diabetes Federation stated that Saudi Arabia had a 17.7% diabetes prevalence rate in 2021.
   
• The insulin rise has caused an increase in chronic wounds (diabetic foot ulcers, and pressure ulcers), and because of the increase there has been a spike in advanced wound therapy devices used to enhance healing times and improve wounds in hospitals and home care.  As the diabetic burden continues in the region, there will be a constant need for advanced wound care.
   
• MEA governments are making large scale investments in healthcare infrastructure development and modernization to improve patient care and lessen reliance on overseas medical care services assistance.  Now that more hospital facilities and specialty wound care centres have been attained advanced wound therapy devices, such as negative pressure wound therapy (NPWT) systems along with smart dressings. These developments are more aligned to modern wound management technology.
   
• Therefore, the aforementioned factors are expected to significantly boost market growth in the region over the forecast period.
   

Wound Therapy Devices Market Share

The market has a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for advanced products for the growing patient population. Companies such as Smith & Nephew, 3M, Mölnlycke Health Care, ConvaTec, and Medtronic are some of the dominant competitors in the market accounting for a combined market share of approximately 52%. Competition in this area arises from continuous technological developments and the ability to offer customized solutions.
 

In developing nations, due to the priority given to cost, multinational companies are squeezed to offer wound therapy devices that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinationals alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.
 

Wound Therapy Devices Market Companies

Some of the eminent market participants operating in the Wound therapy devices industry include:

• B. Braun
• Cardinal Health
• Coloplast
• ConvaTec
• DeRoyal Industries
• Integra LifeSciences
• Lohmann & Rauscher
• Medela
• Medtronic
• MiMedx
• Mölnlycke Health Care
• Organogenesis
• Paul Hartmann
• Smith & Nephew
• 3M
   
• Smith & Nephew enjoys a strong position in the wound therapy industry with its PICO Single-Use Negative Pressure Wound Therapy (NPWT) system. The PICO system provides portability, reduced infection risk, and ease of use, compared to more traditional NPWT devices. Furthermore, Smith & Nephew has a portfolio of wound biologics, including REGRANEX and specialized dressings, to be used on chronic wounds, especially diabetic foot ulcers, all of which have demonstrated clinical findings.
   
• 3M produces Tegaderm antimicrobial dressings and wound closure products that emphasize infection prevention as well as moisture management for both acute and chronic wounds. Their extensive product line includes surgical tapes, hydrocolloids, and silicone-based dressings that provide secure protection for wounds with reduced skin damage.
   
• Mölnlycke's Mepilex silicone foam dressings reduce pain when the dressing is changed and provide patient comfort. Their safetac technology maximizes pain reduction and minimizes skin damage, making it especially favorable for burns, surgical wounds, and fragile skin. Their commitment to the environment is demonstrated by their offering of biodegradable dressings, combined with their use of evidence-based practice.
   

The wound therapy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product Type

• Negative pressure wound therapy
• Hyperbaric oxygen therapy
• Electric stimulation devices
• Pressure relief devices
• Other product types

By Wound Type

• Chronic wounds
• Acute wounds

By End Use

• Hospitals
• Specialty clinics
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE